MOMerve Oğuz

Merve Oğuz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Merve Oğuz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluating patients with Kawasaki disease: can the systemic immune inflammation index predict coronary involvement?

    by Merve Korkut Oğuz, Dolunay Gürses, Münevver Yılmaz, Emine Sayın

    Kawasaki disease is a self-limiting vasculitis of unknown aetiology, and coronary artery lesions are its most common and serious complication. The Systemic Immune-Inflammation Index is a new biomarker of inflammation that may have prognostic value in Kawasaki disease. This study evaluated patients with Kawasaki disease and the prognostic role of Systemic Immune-Inflammation Index in coronary involvement. A total of 62 children with Kawasaki disease and 49 healthy controls were included. Systemic Immune-Inflammation Index was calculated as: neutrophils × platelets/lymphocytes). Systemic Immune-Inflammation Index was also significantly higher in Kawasaki disease patients than controls (2373 ± 2040 vs. 300 ± 218, p < 0.001). Subgroup analysis of the Kawasaki disease patients showed that Systemic Immune-Inflammation Index was significantly higher in patients with coronary artery lesions than in those without ( p < 0.05). In conclusion, Systemic Immune-Inflammation Index is a composite inflammatory biomarker easily obtained from routine blood parameters and may be an independent predictor of coronary artery involvement in Kawasaki disease.


  • Open Access

    Evaluation of Pentraxin-3 levels in children with multisystem inflammatory syndrome

    by Dolunay Gürses, Münevver Yılmaz, Esin Avcı, Merve Oğuz, Emine Sayın, Selçuk Yüksel

    Background: Early recognition of cardiac involvement and prediction of disease prognosis are essential for the management of inflammatory diseases such as multisystem inflammatory syndrome. This study aimed to investigate the role of Pentraxin-3 levels in identifying cardiac involvement and evaluating disease severity in patients with multisystem inflammatory syndrome.Methods: The study included 56 multisystem inflammatory syndrome patients and 26 healthy children as a control group. The multisystem inflammatory syndrome group was divided into those with cardiac involvement (n = 34) and those without (n = 22), as well as those with clinically mild-moderate (n = 30) and severe (n = 26) multisystem inflammatory syndrome. Blood samples for measurement of Pentraxin-3 levels were obtained from all patients before treatment and from the healthy controls.Results: In the patient group, the mean age was 8.2 ± 4 years (range: 2–17 years), and the male-to-female ratio was 1.8. In the control group, these values were 9.5 ± 3.7 years (range: 2–16 years) and 1.9, respectively (p > 0.05). Plasma Pentraxin-3 levels were significantly higher in multisystem inflammatory syndrome patients compared to controls (7.1 ± 5 ng/mL vs. 2.9 ± 2.1 ng/mL, p = 0.001). Patients with cardiac involvement had a significantly higher median Pentraxin-3 level than those without (5.8 ng/mL vs. 4.1 ng/mL, p = 0.004). Severe disease was also associated with a higher median Pentraxin-3 level compared to mild-moderate disease (6.1 ng/mL vs. 4.4 ng/mL, p = 0.001). Pentraxin-3 level was negatively correlated with left ventricular ejection fraction and positively correlated with B-type natriuretic peptide, troponin.Conclusion: Elevated Pentraxin-3 levels in multisystem inflammatory syndrome patients may help predict the clinical course of the disease and cardiac involvement. However, larger-scale prospective studies are needed to further elucidate this.


  • Coronary artery bypass grafting in adolescent with myocardial infarction complicating undiagnosed Kawasaki disease

    by Dolunay Gürses, Münevver Yılmaz, Merve Oğuz, Furkan Ufuk, Ahmet Baltalarlı

    Although Kawasaki disease is often self-limiting, significant cardiovascular sequelae may occur in the acute or late stage. The most common late complication is persistent coronary artery aneurysm, which can lead to myocardial ischaemia and even myocardial infarction. We report a case of coronary artery bypass grafting in a 16-year-old boy with a history of undiagnosed Kawasaki disease. Increased awareness of Kawasaki disease, especially among children between the ages of 6 months and 5 years, can increase early treatment and prevent serious complications that may occur in the future.

  • Open Access

    Successful treatment of acute myocardial injury of Duchenne muscular dystrophy with steroids: a case report

    by Merve Oğuz, Dolunay Gürses, Furkan Ufuk, Münevver Yılmaz, Olcay Güngör

    Background: Duchenne muscular dystrophy (DMD) is an X-linked muscular disease which is caused by the absence of dystrophin. Troponin elevation with acute chest pain may indicate acute myocardial injury in these patients. We report a case of DMD that presented with ACP and troponin elevation, who was diagnosed with acute myocardial injury, and successfully treated with corticosteroids. Case presentation: A 9-year-old with DMD was admitted to the emergency department with the complaint of acute chest pain. His electrocardiogram (ECG) revealed inferior ST elevation and serum troponin T was elevated. The transthoracic echocardiography (TTE) demonstrated inferolateral and anterolateral hypokinesia with depressed left ventricular function. An ECG-gated coronary computed tomography angiography ruled out acute coronary syndrome. Cardiac magnetic resonance imaging revealed mid-wall to sub-epicardial late gadolinium enhancement at the basal to the mid inferior lateral wall of the left ventricle and corresponding hyperintensity on T2-weighted imaging, consistent with acute myocarditis. A diagnosis of acute myocardial injury associated with DMD was made. He was treated with anticongestive therapy and 2 mg/kg/day of oral methylprednisolone. Chest pain resolved the next day, and ST-segment elevation returned to normal on the third day. Troponin T decreased in the sixth hour of oral methylprednisolone treatment. TTE on the fifth day revealed improved left ventricular function. Conclusion: Despite advances in contemporary cardiopulmonary therapies, cardiomyopathy remains the leading cause of death in patients with DMD. Acute chest pain attacks with elevated troponin in patients with DMD without coronary artery disease may indicate acute myocardial injury. Recognition and appropriate treatment of acute myocardial injury episodes in DMD patients may delay the development of cardiomyopathy.


  • Open Access

    Swyer-James-MacLeod Syndrome in a Patient With Eisenmenger Syndrome

    by Dolunay Gürses, Merve Oğuz, Doğangün Yüksel, Furkan Ufuk, Münevver Yılmaz

    Swyer-James-MacLeod syndrome is a condition characterized radiologically by hyperlucency in a single lung lobe associated with reduced vascularity, alveolar hyperdistention, and air trapping in the absence of bronchial airway obstruction. Ventricular septal defect is the most common congenital heart defect in childhood and causes irreversible pulmonary hypertension and Eisenmenger syndrome if not treated in a timely manner. In this case report, we present a 25-year-old patient with Swyer-James-MacLeod syndrome and Eisenmenger syndrome. Including Swyer-James-MacLeod syndrome in the differential diagnosis of patients with atypically distributed pulmonary emphysema and unilateral hyperlucency is important for early diagnosis and timely treatment.

  • Open Access

    Pentraxin 3 levels and correlation with disease severity in patients with acute rheumatic fever

    by Dolunay Gürses, Merve Oğuz, Münevver Yilmaz, Hülya Aybek, Funda Akpinar

    Objectives: This study aims to investigate serum pentraxin 3 (PTX3) levels during acute episode of acute rheumatic fever (ARF) and their relationship with disease severity. Patients and methods: The prospective study was conducted between January 2015 and December 2018 and included 52 ARF patients (22 girls, 30 boys, mean age 10.7±2.1 years; range, 5 to 16 years) experiencing an acute episode and 22 healthy children (13 girls, 9 boys, mean age 10.3±3.8 years; range, 5 to 16 years). ARF patients were classified into three groups based on the clinical course: isolated arthritis (n=17), mild carditis (n=19), and moderate/severe carditis (n=16). Blood samples were collected from all patients before treatment and from the healthy children in the control group to measure PTX3 levels. PTX3 was measured using sandwich enzyme-linked immunosorbent assay method. Results: Plasma PTX3 levels were significantly higher in ARF group compared to the control group (4.7±5.2 and 1.2±1.7 ng/mL, p


  • Open Access

    Çocuk sağlığı ve hastalıkları kliniğinde sağlık çalışanlarına yönelik şiddet: üçüncü düzey bir hastane örneği

    by Merve Oğuz

    Violence in health is an important public health problem that threatens community peace. In our study, it was aimed to examine the state of exposure to violence among employees in our clinic in the last one year and our employees’ opinions and attitudes about violence. The study was performed cross-sectionally. In this study the Violent Incident Form developed by Arnetz (1998) was used as a data collection tool. A total of 182 healthcare workers were included in the study. Of the participants, 14 (7.7%) were faculty members, 37 (20.3%) were physicians, 24 (13.2%) were interns, 70 (38.5%) were nurses, 10 (5.5%) were medical secretaries, and 27 (14.8%) were ancillary health personnel. The female/male ratio was 143/39. Seventy-nine (43.4%) of the employees had been exposed to violence at least once in the last year. Of those experiencing violence, 57 (72%) were female, 28 (35%) were nurses, 21 (27%) were residents, 16 (20%) were interns, five (6.5%) were faculty members, five (6.5%) were allied health personnel, and four (5%) were medical secretaries. Physicians were exposed to violence with a higher rate (p<0.05). Exposure to violence was observed most frequently in the pediatric emergency department. Of all the violent incidents, 58% occurred during night shifts and 46% occurred during examination/treatment/physical care. The perpetrator was a patient in only one incident, the other perpetrators were patients’ relatives, and 63% of the perpetrators were men. All violent incidents involved verbal violence, seven (8.8%) incidents contained elements of physical violence, such as spitting, pushing, kicking, biting, restraining or using an object. Only 29 (36.7%) of the 79 staff reported violence, and 50 (63.3%) did not take any action after the violence. Violence in health is a common and serious problem even in tertiary hospitals. In our study, only one-third of the affected staff reported violence after exposure to violence. The risk of violence should be reduced in order to ensure a safe work environment, which will be possible by raising awareness of healthcare workers and effective implementation of violence prevention programs.


  • Open Access

    Clinical and Echocardiographic Evaluation of Our Patients with Myopericarditis

    by Dolunay Gürses, Merve Oğuz, Münevver Yilmaz

    Amaç: Pediatrik grupta göğüs ağrısı, nefes darlığı gibi belirtilerle başvuran hastalarda biyokimyasal belirteçlerde artış, elektrokardiyografik değişikliklerin varlığında ayırıcı tanıda miyokardit de düşünülmelidir. Bu çalışmada, son yıllarda sık gördüğümüz bu hasta grubunun geriye dönük değerlendirmesi amaçlanmıştır. Gereç ve Yöntemler: Ocak 2014-Aralık 2017 tarihleri arasında miyoperikardit tanısı alan 18 hasta retrospektif değerlendirildi. Hastaların demografik özellikleri, fizik bakı, laboratuvar sonuçları kaydedildi. Bulgular: Hastaların yaş aralığı beş ay-17 yıl (12,8±5,0) arasında bulundu. Başvuru yakınması 16 (%88) hastada göğüs ağrısı, bir hastada ateş, bir hastada solunum sıkıntısı, efor kapasitesinde azalma idi. On iki hastada üst solunum yolu enfeksiyonu, bir hastada akrep sokması öyküsü mevcuttu. Beyaz küre sayısı 10.045±2.706/mm3 (5900-14580), C-reaktif protein 5,3±6,3 mg/dL (0,01-19) idi. Kardiyak enzimler tüm hastalarda yüksek bulundu. Kreatin kinazmiyokardiyal bant 36,2±11,2 ng/mL (0,8-167), troponin T 0,61±0,15 ng/mL (0,051-2,65) saptandı. Kalp yetersizliği bulguları nedeniyle 7 hastadan gönderilen pro-B tipi natriüretik peptit düzeyi ortalama 5,122±2,851 pg/mL (110-20286) idi. Bir hastada Cytomegalovirus immunglobulin M, iki hastada Epstein-Barr virüsü-immünglobulin M pozitifti. Multipleks polimeraz zincir redaksiyonu solunum yolu panelinde beş hastada Rhinovirus, üç hastada Adenovirus saptandı. Elektrokardiyografide (EKG); dokuz hastada sinüs taşikardisi, 11 hastada ST-T değişiklikleri ve altı hastada QRS voltaj düşüklüğü bulundu. Hastaların ejeksiyon fraksiyonu ortalama %68,2±2,9 (35-88) idi. Altı hastada mitral yetmezlik, 10 hastada perikardiyal effüzyon saptandı. Üç hastada miyokard perfüzyon sintigrafisi, iki hastada kardiyak manyetik rezonans görüntüleme ile miyoperikardit doğrulandı. Tedavide 10 (30 mg/kg/gün) hastaya ibuprofen, izlemlerde troponin T düzeylerinde artış saptanan 12 hastaya intravenöz immünglobulin (2 g/kg/24 saat) verilmişti. Akrep sokması sonrası toksik miyokardit gelişen hastaya doksasozin ve antivenom uygulandı. Kardiyak enzimler 6±3,1 (2-13) gün yüksek kaldı. Hastaların ortalama yatış süresi 6±3,6 (2-16) gündü. Sonuç: Kardiyak enzimlerde yükseklik saptanan ve/veya EKG değişiklikleri olan hastalar miyokardit açısından değerlendirilmelidir.